- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/34 - Nitrogen atom attached in position 6, e.g. adenine
Patent holdings for IPC class C07D 473/34
Total number of patents in this class: 1051
10-year publication summary
|
91
|
102
|
86
|
76
|
64
|
45
|
57
|
53
|
50
|
23
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ono Pharmaceutical Co., Ltd. | 424 |
26 |
| Gilead Sciences, Inc. | 2219 |
25 |
| K36 Therapeutics, Inc. | 31 |
23 |
| Novartis AG | 10279 |
22 |
| Intellikine LLC | 41 |
18 |
| Dana-Farber Cancer Institute, Inc. | 2657 |
16 |
| Rhizen Pharmaceuticals AG | 57 |
16 |
| Infinity Pharmaceuticals, Inc. | 96 |
15 |
| Amgen Inc. | 4418 |
14 |
| Univerzita Palackeho V Olomouci | 135 |
14 |
| AstraZeneca AB | 2815 |
13 |
| Epizyme, Inc. | 359 |
13 |
| Sloan-Kettering Institute for Cancer Research | 609 |
13 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
13 |
| Incyte Corporation | 1072 |
12 |
| Memorial Sloan-Kettering Cancer Center | 2039 |
12 |
| The Scripps Research Institute | 1342 |
12 |
| F. Hoffmann-La Roche AG | 7838 |
11 |
| Gilead Calistoga LLC | 35 |
11 |
| The Regents of the University of California | 20694 |
10 |
| Other owners | 742 |